Filing Details
- Accession Number:
- 0001140361-16-090424
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-20 20:44:18
- Reporting Period:
- 2016-12-16
- Filing Date:
- 2016-12-20
- Accepted Time:
- 2016-12-20 20:44:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1428336 | Healthequity Inc | HQY | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1352786 | S Manu Rana | 280 Park Avenue, 3Rd Floor New York NY 10017 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-12-16 | 111,975 | $41.26 | 270,377 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2016-12-16 | 48,025 | $42.22 | 222,352 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2016-12-19 | 124,752 | $40.13 | 97,600 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2016-12-19 | 1,600 | $41.01 | 96,000 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2016-12-20 | 96,000 | $40.11 | 0 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $21.27 | 2026-02-01 | 15,000 | 15,000 | Direct | |
Common Stock | Restricted Stock Unit | $0.00 | 795 | 795 | Direct | ||
Common Stock | Stock Option (right to buy) | $1.25 | 2021-10-25 | 7,500 | 7,500 | Direct | |
Common Stock | Stock Option (right to buy) | $1.25 | 2022-04-26 | 15,000 | 15,000 | Direct | |
Common Stock | Stock Option (right to buy) | $1.50 | 2023-05-09 | 15,000 | 15,000 | Direct | |
Common Stock | Stock Option (right to buy) | $14.00 | 2024-07-30 | 15,000 | 15,000 | Direct | |
Common Stock | Stock Option (right to buy) | $25.39 | 2025-03-26 | 15,000 | 15,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2026-02-01 | 15,000 | 15,000 | Direct |
795 | 795 | Direct | |
2021-10-25 | 7,500 | 7,500 | Direct |
2022-04-26 | 15,000 | 15,000 | Direct |
2023-05-09 | 15,000 | 15,000 | Direct |
2024-07-30 | 15,000 | 15,000 | Direct |
2025-03-26 | 15,000 | 15,000 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.97 to $41.96, inclusive. The reporting person undertakes to provide to the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4) and (5) to this Form 4.
- All securities are held of record by Financial Partners Fund I, L.P. ("FPF I"), a Delaware limited partnership. The reporting person is a managing principal of FPF I. The reporting person disclaims beneficial ownership of the securities held by FPF I except to the extent of his pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.97 to $42.65, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.99 to $40.75, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.07 to $40.325, inclusive.
- The option became exercisable as to 7,500 shares upon the reporting person's reelection to the issuer's board of directors at the issuer's 2016 Annual Meeting of Stockholders held on June 23, 2016. The remaining 7,500 shares will become exercisable on January 31, 2017; provided, that the reporting person continues to serve as a director of the issuer through such date.
- Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- The restricted stock units vested as to 397 shares on August 1, 2016 and will vest as to the remaining 398 shares on November 1, 2016. Vested shares will be delivered to the reporting person upon the earlier of a change of control of the issuer (as defined in the issuer's 2014 equity incentive plan), or the reporting person's termination of service (as defined in the issuer's 2014 equity incentive plan), or the reporting person's death.
- The option is immediately exercisable.